Tempus CEO Eric Lefkofsky on using AI to revolutionize cancer treatment
Tempus founder and CEO Eric Lefkofsky joins 'The Claman Countdown' to discuss how artificial intelligence is transforming precision medicine.
We are generating necessary data to determine what treatments patients need: Tempus CEO
Tempus CEO Eric Lefkofsky discusses the company's artificial intelligence-driven precision medicine partnership with Merck on ‘The Claman Countdown.’
Employers pull back on weight-loss drug coverage
Motley Fool Asset Management chief investment strategist Bill Mann analyzes Eli Lilly's long-term growth potential amid shifts in employer coverage for weight-loss drugs on ‘The Claman Countdown.’
Moderna stock jumps amid announcement of melanoma vaccine treatment
Siebert Financial CIO Mark Malek analyzes the biotech sector bounce, Moderna's growth outlook and Nvidia's upcoming earnings report on ‘Making Money.’
Costco plots major expansion into senior healthcare with Medicare partnership
In a first-of-its-kind venture, Costco is partnering with SCAN Health Plan on senior-focused insurance products that could include pharmacy, vision and hearing benefits.
Novo Nordisk CEO sees ‘long runway’ for weight-loss drugs as obesity grips America
Novo Nordisk CEO argues weight loss drugs could slash healthcare costs and boost productivity as GLP-1 adoption remains in its early innings.
GoodRx CEO details partnership with TrumpRx
GoodRx President and CEO Wendy Barnes discusses the company's partnership with TrumpRx on 'The Claman Countdown.'
GoodRx CEO details TrumpRx partnership to lower prescription drug costs
GoodRx CEO Wendy Barnes discusses the company's partnership with TrumpRx and efforts to lower prescription drug costs on ‘The Claman Countdown.’
Strategist points to healthcare if investors want to diversify portfolio outside of AI
Empower chief investment strategist Marta Norton joins 'The Claman Countdown' to discuss the resilient consumer and how to diversify your portfolio.
AI is transforming healthcare, and the benefits are only growing: Dr. Peter Fleischut
NewYork-Presbyterian Executive Vice President Dr. Peter Fleischut discusses how AI is improving patient care, enhancing clinical decision-making, transforming anesthesia and shaping the future of medicine on 'Mornings with Maria.'
How AI could redefine healthcare by the end of the decade
IEEE's 2030 report ranks health technologies as the most transformative megatrend, driven by AI-powered personalized medicine and early diagnostics.
Johnson & Johnson commits to $55B, 4-year US investment plan
Johnson & Johnson CFO Joe Wolk discusses the company's second-quarter earnings and the performance of its medical technology unit, including Impella heart pumps, on ‘The Claman Countdown.’
FDA moves to expose hidden foreign drug factories, strengthen domestic production in sweeping rule proposal
The FDA's new website and regulatory overhaul aim to close a loophole that lets foreign factories hide raw drug materials from U.S. supply chain oversight.
Pfizer CEO on primary care, GLP-1 outlook and innovation timeline
Albert Bourla, Pfizer Chairman & CEO, discusses strong performance in primary care and the game-changing Metsera acquisition for GLP-1 set to launch by 2028 on 'Mornings with Maria.'
AI will be 'transformational' in drug development and discovery, Pfizer CEO says
Pfizer CEO Albert Bourla details $70B US investment in manufacturing and R&D, discussing oncology advancements, the GLP-1 drug race, and AI's transformative role in drug development on 'Mornings with Maria.'
Skilled trades resurgence collides with AI as manufacturers embrace emerging tech
Made by Anderson Brands co-founders Ali and Kory Anderson discuss how U.S. manufacturers are embracing artificial intelligence on ‘The Bottom Line.’
Zscaler CEO says Mythos is a ‘tailwind,’ not a threat to cybersecurity firms
Zscaler CEO Jay Chaudhry discusses the company’s recent numbers, the impact of Mythos on the cybersecurity industry and more on ‘The Claman Countdown.’
USC president warns universities cannot ignore AI revolution: ‘This technology is not going away’
University of Southern California president Beong-Soo Kim explains the university’s strategy for equipping its graduates with skills for an evolving job market on ‘The Claman Countdown.’
There's a 'huge momentum' around data centers and AI, Nano Nuclear founder says
Nano Nuclear Energy founder & chairman Jay Yu discusses the company's MOU with Supermicro to power AI data centers, highlights nuclear energy's role in space and maritime and more on 'Mornings with Maria.'
Build-A-Bear recalls 36,000 plush bears over choking hazard from detachable zipper slider on pouch
About 36,000 Build-A-Bear Heartwarming Hugs weighted plush bears are being recalled over a choking hazard involving a detachable zipper slider, CPSC says.